Jean-Charles Nault

37PUBLICATIONS
191CO-AUTHORS
Cancer diagnosisPolitical economy and social changeHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|May 20, 2026
Role and Characteristic of Multidisciplinarity in Hepatocellular Carcinoma Management and Care Pathway Certification: Bottom-Up Approach of the MDT Project in Italy.

|Sep 04, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database.

Alessandro Loglio, Ivan Gardini, Massimiliano Conforti

|Jun 13, 2025
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis.

Rodolfo Sacco, Edoardo G Giannini, Raffaella Tortora

|Feb 27, 2025
Glucagon-like peptide-1 receptor agonist use is associated with a lower risk of major adverse liver-related outcomes: a meta-analysis of observational cohort studies.

Ciro Celsa, Grazia Pennisi, Adele Tulone

|Jan 08, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma.

Edoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres

|Dec 26, 2024
Reply: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.

Ciro Celsa, Giuseppe Cabibbo, David J Pinato

Pageof 7

Frequent Collaborators

13 joint publications

Ciro Celsa

8 joint publications

Franco Trevisani

8 joint publications

Calogero Cammà

8 joint publications

Edoardo Giovanni Giannini